These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8553527)

  • 1. Bioavailability of different benzimidazole volume-dose formulations in sheep.
    Benchaoui HA; Futter IJ; Holton LL; Gettinby G; McKellar QA
    Vet Rec; 1995 Aug; 137(7):171-2. PubMed ID: 8553527
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative disposition kinetics of albendazole in sheep following oral and intraruminal administration.
    Swarnkar CP; Sanyal PK; Singh D; Khan FA; Bhagwan PS
    Vet Res Commun; 1998 Dec; 22(8):545-51. PubMed ID: 10066128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single and divided dose administration on the pharmacokinetics of albendazole in sheep and goat.
    Sanyal PK
    Vet J; 1998 May; 155(3):311-6. PubMed ID: 9638078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.
    Capece BP; Castells G; Pérez F; Arboix M; Cristòfol C
    Vet Res Commun; 2000 Jul; 24(5):339-48. PubMed ID: 10868551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.
    Aksit D; Yalinkilinc HS; Sekkin S; Boyacioğlu M; Cirak VY; Ayaz E; Gokbulut C
    BMC Vet Res; 2015 May; 11():124. PubMed ID: 26012791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers.
    Rigter IM; Schipper HG; Koopmans RP; van Kan HJ; Frijlink HW; Kager PA; Guchelaar HJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1051-4. PubMed ID: 14982808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
    Lifschitz A; Virkel G; Mastromarino M; Lanusse C
    Vet Res Commun; 1997 Apr; 21(3):201-11. PubMed ID: 9090047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
    Merino G; Alvarez AI; Redondo PA; Garcia JL; Larrodé OM; Prieto JG
    Res Vet Sci; 1999 Jun; 66(3):281-3. PubMed ID: 10333473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of netobimin metabolites in pregnant ewes.
    Cristòfol C; Franquelo C; Navarro M; Carretero A; Ruberte J; Arboix M
    Res Vet Sci; 1997; 62(2):117-20. PubMed ID: 9243708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
    Formentini EA; Mestorino N; Errecalde JO
    Vet Res Commun; 2005 Oct; 29(7):595-608. PubMed ID: 16142607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and pharmacokinetics of albendazole after oral administration to chickens.
    Csikó GY; Banhidi GY; Semjén G; Laczay P; Ványine Sándor G; Lehel J; Fekete J
    J Vet Pharmacol Ther; 1996 Aug; 19(4):322-5. PubMed ID: 8866465
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a short-term reduction in feed on the pharmacokinetics and efficacy of albendazole in sheep.
    Hennessy DR; Ali DN; Sillince J
    Aust Vet J; 1995 Jan; 72(1):29-30. PubMed ID: 8787523
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipidic matrix of albendazole: an alternative for systemic infections.
    Savio E; Domínguez L; Malanga A; Quevedo D; Saldaña J; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Oct; 137(9):345-9. PubMed ID: 9859596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections?
    Domínguez L; Savio E; Saldaña J; Malanga A; Quevedo D; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Nov; 137(10):383-6. PubMed ID: 9880943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ricobendazole in calves.
    Formentini EA; Mestorino ON; Mariño EL; Errecalde JO
    J Vet Pharmacol Ther; 2001 Jun; 24(3):199-202. PubMed ID: 11442798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental transfer of albendazole sulphoxide enantiomers in sheep.
    Capece BP; Pérez R; Andaluz A; Pérez F; Garcia F; Castells G; Arboix M; Cristòfol C
    Vet J; 2002 Mar; 163(2):155-60. PubMed ID: 12093190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the ionophore antibiotic monensin on the ruminal biotransformation of benzimidazole anthelmintics.
    Virkel G; Lifschitz A; Sallovitz J; Inza G; Lanusse C
    Vet J; 2004 May; 167(3):265-71. PubMed ID: 15080875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition kinetics of albendazole following the administration of single and divided doses to cattle and buffalo.
    Sanyal PK
    Vet Res Commun; 1998 Feb; 22(2):87-96. PubMed ID: 9563167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.